GCAT

gene product
KBL
The degradation of L-threonine to glycine consists of a two-step biochemical pathway involving the enzymes L-threonine dehydrogenase and 2-amino-3-ketobutyrate coenzyme A ligase. L-Threonine is first converted into 2-amino-3-ketobutyrate by L-threonine dehydrogenase. This gene encodes the second enzyme in this pathway, which then catalyzes the reaction between 2-amino-3-ketobutyrate and coenzyme A to form glycine and acetyl-CoA. The encoded enzyme is considered a class II pyridoxal-phosphate-dependent aminotransferase. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 14. [provided by RefSeq, Jan 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
108 antibodies from 21 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
46 antibodies
Biorbyt
5 antibodies
Aviva Systems Biology
4 antibodies
NovoPro Bioscience Inc.
3 antibodies
Abgent
3 antibodies
Invitrogen Antibodies
3 antibodies
ProSci
2 antibodies
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
7 antibodies
OriGene
2 antibodies
Atlas Antibodies
1 antibody
Novus Biologicals
1 antibody
MyBioSource
3 antibodies
Creative Diagnostics
3 antibodies
Acris Antibodies GmbH
3 antibodies
Abnova Corporation
2 antibodies
Creative Biolabs
1 antibody
Boster Biological Technology
1 antibody
Sigma-Aldrich
2 antibodies
United States Biological
3 antibodies